Updated: Jul 27, 2026

Debanjana Chatterjee's Stock Ratings

Jones Trading Analyst

Debanjana Chatterjee is an analyst at Jones Trading. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Overall Average Return

34.5%

Smart Score

72.9%

Overall Average Return Percentile

88th

Number of Ratings

22
Buy NowGet Alert
06/30/2026ATHEBuy Now
Alterity Therapeutics
$4.70240.43% → $16Initiates → BuyGet Alert
06/29/2026TBPHBuy Now
Theravance Biopharma
$16.89DowngradeBuy → HoldGet Alert
04/28/2026SIONBuy Now
Sionna Therapeutics
$45.9537.12%$52 → $63MaintainsBuyGet Alert
04/17/2026SYREBuy Now
Spyre Therapeutics
$99.38-4.41%$64 → $95MaintainsBuyGet Alert
04/16/2026HYFTBuy Now
MindWalk Holdings
$1.44248.19% → $5Initiates → BuyGet Alert
04/10/2026ABCLBuy Now
AbCellera Biologics
$5.29108.14% → $11Initiates → BuyGet Alert
03/19/2026TRVIBuy Now
Trevi Therapeutics
$17.7335.36%$25 → $24MaintainsBuyGet Alert
03/04/2026NTLABuy Now
Intellia Therapeutics
$10.64172.55% → $29UpgradeHold → BuyGet Alert
01/05/2026ARMPBuy Now
Armata Pharmaceuticals
$4.64223.28% → $15Initiates → BuyGet Alert
12/01/2025SYREBuy Now
Spyre Therapeutics
$99.38-35.6% → $64UpgradeHold → BuyGet Alert
11/11/2025NTLABuy Now
Intellia Therapeutics
$10.64DowngradeBuy → HoldGet Alert
09/08/2025SIONBuy Now
Sionna Therapeutics
$45.950.12% → $46Initiates → BuyGet Alert
06/17/2025TBPHBuy Now
Theravance Biopharma
$16.8942.1% → $24Initiates → BuyGet Alert
06/06/2025SGMTBuy Now
Sagimet Biosciences
$7.35267.35%$15 → $27MaintainsBuyGet Alert
04/28/2025TVRDBuy Now
Tvardi Therapeutics
$2.471478.95% → $39Initiates → BuyGet Alert
03/26/2025KALVBuy Now
KalVista Pharma
$30 → $30MaintainsBuyGet Alert
03/13/2025CTNMBuy Now
Contineum Therapeutics
$14.1063.18% → $23Initiates → BuyGet Alert
01/27/2025SGMTBuy Now
Sagimet Biosciences
$7.35471.43% → $42Initiates → BuyGet Alert
12/11/2024SYREBuy Now
Spyre Therapeutics
$99.38Initiates → HoldGet Alert
09/27/2024KALVBuy Now
KalVista Pharma
→ $35Initiates → BuyGet Alert
09/19/2024PHVSBuy Now
Pharvaris
$33.9635.45% → $46Initiates → BuyGet Alert
09/17/2024NTLABuy Now
Intellia Therapeutics
$10.64285.33% → $41Initiates → BuyGet Alert